We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $245M
1-Year Est. Return 23.8%
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
+23.8%
3 Year Est. Return
+70.62%
5 Year Est. Return
+83.19%
10 Year Est. Return
+679.91%
AUM
$132M
AUM Growth
+$5.13M
Cap. Flow
-$1.05M
Cap. Flow %
-0.79%
Top 10 Hldgs %
34.2%
Holding
580
New
91
Increased
78
Reduced
127
Closed
71

Top Buys

Rank Stock Value
1
SCHP icon
Schwab US TIPS ETF
SCHP
+$723K
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$274K
3
NFLX icon
Netflix
NFLX
+$236K
4
BND icon
Vanguard Total Bond Market
BND
+$235K
5
HSIC icon
Henry Schein
HSIC
+$234K

Top Sells

Rank Stock Value
1
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$579K
2
VGSH icon
Vanguard Short-Term Treasury ETF
VGSH
+$468K
3
MRK icon
Merck
MRK
+$299K
4
WSC icon
WillScot Mobile Mini Holdings
WSC
+$252K
5
TITN icon
Titan Machinery
TITN
+$251K

Sector Composition

Rank Sector Weight
1 Technology 7.42%
2 Healthcare 4.25%
3 Industrials 3.75%
4 Financials 3.68%
5 Consumer Discretionary 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDN
476
Brandywine Realty Trust
BDN
$546M
$1.89K ﹤0.01%
+400
New +$2.35K
HT
477
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$1.8K ﹤0.01%
+268
New +$2.17K
CE icon
478
Celanese
CE
$4.84B
$1.74K ﹤0.01%
16
– –
SLM icon
479
SLM Corp
SLM
$5.21B
$1.72K ﹤0.01%
139
– –
IDYA icon
480
IDEAYA Biosciences
IDYA
$3.55B
$1.72K ﹤0.01%
+125
New +$2.08K
CSTL icon
481
Castle Biosciences
CSTL
$949M
$1.7K ﹤0.01%
+75
New +$1.83K
WRB icon
482
W.R. Berkley
WRB
$26.2B
$1.68K ﹤0.01%
41
– –
RJF icon
483
Raymond James Financial
RJF
$34.8B
$1.49K ﹤0.01%
16
– –
VERV
484
DELISTED
Verve Therapeutics
VERV
$1.46K ﹤0.01%
101
– –
NUVB icon
485
Nuvation Bio
NUVB
$2.15B
$1.44K ﹤0.01%
+867
New +$1.76K
DNA icon
486
Ginkgo Bioworks
DNA
$488M
$1.33K ﹤0.01%
25
– –
NVTA
487
DELISTED
Invitae Corporation
NVTA
$1.26K ﹤0.01%
931
– –
TWST icon
488
Twist Bioscience
TWST
$7.81B
$1.25K ﹤0.01%
83
– –
SURF
489
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1.25K ﹤0.01%
1,785
– –
MTCH icon
490
Match Group
MTCH
$8.52B
$1.23K ﹤0.01%
32
– –
LGND icon
491
Ligand Pharmaceuticals
LGND
$5.7B
$1.1K ﹤0.01%
+15
New +$1.07K
RLAY icon
492
Relay Therapeutics
RLAY
$4.37B
$1.07K ﹤0.01%
+65
New +$1.17K
CELL
493
DELISTED
PhenomeX Inc. Common Stock
CELL
$1.06K ﹤0.01%
916
– –
EWO icon
494
iShares MSCI Austria ETF
EWO
$188M
$992 ﹤0.01%
49
– –
SPOT icon
495
Spotify
SPOT
$103B
$935 ﹤0.01%
7
– –
EWZ icon
496
iShares MSCI Brazil ETF
EWZ
$8.56B
$849 ﹤0.01%
31
– –
CTVA icon
497
Corteva
CTVA
$50.2B
$844 ﹤0.01%
14
-2,081
-99% -$127K
TRMB icon
498
Trimble
TRMB
$13.4B
$786 ﹤0.01%
15
– –
VIAV icon
499
Viavi Solutions
VIAV
$10.5B
$780 ﹤0.01%
72
– –
PPLI
500
People Inc
PPLI
$3B
$774 ﹤0.01%
18
– –
18 19
20
21 22

Similar funds

LHCM
Lloyd Harbor Capital Management Cold Spring Harbor, New York $245M AUM 141.83% 1-Year Est. Return
JP
JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return
BNMT
Bawa N Mallick Trust Forest Hills, New York $244M AUM 19.8% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return

C.M. Bidwell & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, C.M. Bidwell & Associates held 580 positions worth $132M, up 4% from $127M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

C.M. Bidwell & Associates's Q1 2023 filing shows 91 new, 78 increased, 127 reduced and 71 closed positions. Its largest new stake was Henry Schein: 2,867 shares worth $234K. The largest sale was Schwab U.S Small- Cap ETF, an estimated $579K.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 7.1% a quarter earlier, followed by Healthcare and Industrials.

  • C.M. Bidwell & Associates's largest Q1 2023 buy was Henry Schein: 2,867 shares worth $234K.
  • C.M. Bidwell & Associates added most to Schwab US TIPS ETF in Q1 2023, an estimated $723K increase.
  • C.M. Bidwell & Associates's biggest Q1 2023 reduction was Schwab U.S Small- Cap ETF, cutting an estimated $579K.
  • C.M. Bidwell & Associates fully exited WillScot Mobile Mini Holdings in Q1 2023, selling an estimated $252K.
  • C.M. Bidwell & Associates's ten largest holdings make up 34% of its $132M portfolio in Q1 2023.
  • C.M. Bidwell & Associates opened 91 new positions and closed 71 in Q1 2023.
  • C.M. Bidwell & Associates's portfolio value rose 4% quarter-over-quarter to $132M.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2023, filed 12 May 2023.